Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115748) titled 'Clinical study on the treatment of type 2 diabetes mellitus complicated with CKD with Sangzhi alkaloids' on Dec. 30, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Zhejiang Provincial People's Hospital
Condition:
Type 2 diabetes mellitus complicated with CKD
Intervention:
Experimental group:Sangzhi alkaloids
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-01
Target Sample Size: Experimental group:30;Control group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=303012
Published by HT...